(NASDAQ: CLOV) Clover Health Investments's forecast annual revenue growth rate of -13.07% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.
Clover Health Investments's revenue in 2024 is $2,033,720,000.On average, 1 Wall Street analysts forecast CLOV's revenue for 2024 to be $616,688,643,191, with the lowest CLOV revenue forecast at $616,688,643,191, and the highest CLOV revenue forecast at $616,688,643,191. On average, 1 Wall Street analysts forecast CLOV's revenue for 2025 to be $636,054,578,416, with the lowest CLOV revenue forecast at $636,054,578,416, and the highest CLOV revenue forecast at $636,054,578,416.
In 2026, CLOV is forecast to generate $662,948,959,049 in revenue, with the lowest revenue forecast at $662,948,959,049 and the highest revenue forecast at $662,948,959,049.